Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag + IST for Severe Aplastic Anemia
NCT05720234Phase 2Unknown
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Nov 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in aplastic anemia, sponsored by Institute of Hematology and Blood Diseases Hospital. Status: unknown.
02
Drugs
avatrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT05720234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05720234.